People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Fintech, Healthtech, Biotechnology, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Wealthtech Holdings, LLC | — | Fintech | Series D+ | $188.5M | $5.3B | 2021 |
| Adagio Medical, Inc. | — | Healthtech | Series C | $81.6M | $128.0M | 2017 |
| Harpoon Medical, Inc. | — | Biotechnology | Seed | $7.8M | $173.2M | 2014 |
| Routing Co | — | Other Technology | Series A | $6.1M | $139.3M | 2020 |
| NP Adventure Atlanta, LLC | — | Other | Seed | $1.3M | $4.1M | 2025 |
| KEIPhone, Inc. | — | Other | Pre-Seed | $365K | $1.4M | 2022 |
James Cox at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Cox on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Olav B. Bergheim | 1 | 13 |
| Reed Sturtevant | 1 | 8 |
| Hugh B. Neuharth | 1 | 7 |
| James Pade | 1 | 6 |
| Scott Kauffman | 1 | 6 |
| Zach Scheiner | 1 | 6 |
| Doug Smith | 1 | 5 |
| Mark Collins | 1 | 5 |
| Kyparissia Sirinakis | 1 | 4 |
| William Niland | 1 | 4 |
| John Wise | 1 | 4 |
| Hugh Neuharth | 1 | 2 |
| Peter Boyd | 1 | 2 |
| James Gammie | 1 | 2 |
| Colin Close | 1 | 2 |
| MICHAEL ZHAO | 1 | 2 |
| Tuan Huynh | 1 | 2 |
| Olav Bergheim | 1 | 2 |
| Lewis Frazier | 1 | 1 |
| Paul Luc Heyvaert | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.